3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Pancreatic Neoplasms
1
Melanoma
1
Colorectal Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Gemcitabine
27
Taxes
9
Capecitabine
8
Albumin-Bound Paclitaxel
6
pembrolizumab
5
Radiosurgery
5
Oxaliplatin
5
Bevacizumab
5
130-nm albumin-bound paclitaxel
5
Surgical Procedures, Operative
4
Specimen Handling
4
Secretin
4
Fluorouracil
4
Drug Therapy
4
Ascorbic Acid
4
durvalumab
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Irinotecan
3
Cyclophosphamide
3
Cisplatin
3
Biopsy
3
palbociclib
2
methylnaltrexone
2
folfirinox
2
fludarabine
2
entinostat
2
aldesleukin
2
Trastuzumab
2
Standard of Care
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Pancreatic Neoplasms
×
yeast-CEA vaccine
×
Clear all
NCT03563144
2025-02-21
QUILT-3.088: NANT Pancreatic Cancer Vaccine
ImmunityBio, Inc.
Phase 2
Withdrawn